These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14414164)

  • 1. The role of aldosterone in man. Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignant hypertension.
    LARAGH JH
    JAMA; 1960 Sep; 174():293-5. PubMed ID: 14414164
    [No Abstract]   [Full Text] [Related]  

  • 2. [CURRENT INFORMATION ON THE ROLE OF THE RENAL-ADRENAL SYSTEM IN THE REGULATION OF BLOOD PRESSURE, ELECTROLYTES AND WATER METABOLISM].
    PAZOUREK M; KUECHEL O
    Lek Veda Zahr; 1964 Jun; 6():110-4. PubMed ID: 14180771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent progress concerning the pathogenesis of arterial hypertension].
    Andreotti L
    Minerva Med; 1976 Jun; 67(32):2039-67. PubMed ID: 951034
    [No Abstract]   [Full Text] [Related]  

  • 4. ANGIOTENSIN.
    PALMER HC
    J Kans Med Soc; 1964 Oct; 65():503-8. PubMed ID: 14214402
    [No Abstract]   [Full Text] [Related]  

  • 5. Renin, angiotensin, aldosterone and hormonal regulation of arterial pressure and salt balance. Introductory remarks.
    Laragh JH
    Fed Proc; 1967; 26(1):39-41. PubMed ID: 4289566
    [No Abstract]   [Full Text] [Related]  

  • 6. INTERACTION BETWEEN ALDOSTERONE SECRETION, SODIUM AND POTASSIUM BALANCE, AND ANGIOTENSIN ACTIVITY IN MAN: STUDIES IN HYPERTENSION AND CIRRHOSIS.
    LARAGH JH; CANNON PJ; AMES RP
    Can Med Assoc J; 1964 Jan; 90(4):248-56. PubMed ID: 14111729
    [No Abstract]   [Full Text] [Related]  

  • 7. CHEMISTRY AND THERAPY OF MALIGNANT HYPERTENSION.
    BJOERK S
    Biochem Clin; 1963; 2():285-97. PubMed ID: 14095803
    [No Abstract]   [Full Text] [Related]  

  • 8. NORMAL AND ALTERED FUNCTION OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN MAN: APPLICATIONS IN CLINICAL AND RESEARCH MEDICINE.
    CONN JW; ROVNER DR; COHEN EL
    Ann Intern Med; 1965 Aug; 63():266-84. PubMed ID: 14318467
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormonally maintained high blood pressure following adrenalectomy in rats with adrenal-regeneration hypertension and its possible significance in the etiology of that disorder.
    Hall CE; Holland OB; Hall O
    Can J Physiol Pharmacol; 1968 Mar; 46(2):269-74. PubMed ID: 5660185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Advances in our knowledge on disorders of blood pressure regulation].
    Klaus D
    Med Welt; 1974 Dec; 25(49):2044-50. PubMed ID: 4613996
    [No Abstract]   [Full Text] [Related]  

  • 11. MALIGNANT HYPERTENSION AND ALDOSTERONE SECRETION. INFLUENCE OF REVERSAL AND PROGRESSION OF THE SYNDROME IN TWO CASES.
    SAMBHI MP; BECK JC; VENNING EH
    Am J Med; 1963 Aug; 35():251-6. PubMed ID: 14057627
    [No Abstract]   [Full Text] [Related]  

  • 12. The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hypertension.
    Laragh JH; Sealey JE; Niarchos AP; Pickering TG
    Fed Proc; 1982 Jun; 41(8):2415-23. PubMed ID: 7084486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDOSTERONE SECRETION RATE AND ELECTROLYTE BALANCE STUDIES ON THREE PATIENTS WITH HYPERTENSION. INFLUENCE OF GUANETHIDINE, HYDRALAZINE AND METHYCLOTHIAZIDE.
    SAMBHI MP; VENNING EH; BECK JC
    Metabolism; 1964 Mar; 13():212-20. PubMed ID: 14127688
    [No Abstract]   [Full Text] [Related]  

  • 14. RECENT ADVANCES IN HYPERTENSION.
    WILSON C
    Can Med Assoc J; 1964 Oct; 91(18):964-70. PubMed ID: 14217261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anephric man].
    Toussaint C; Verniory A; Naets JP; Corvilain J; Lambert PP
    J Urol Nephrol (Paris); 1968 Dec; 74(12):933-49. PubMed ID: 4886360
    [No Abstract]   [Full Text] [Related]  

  • 16. [EFFECTS OF PROTRACTED TREATMENT WITH ALDOSTERONE ON PRESSOR RESPONSES TO ANGIOTENSIN AND ON WATER-ELECTROLYTE DISTRIBUTION IN NORMAL DOGS].
    BERETTA R; FANTINI F; LANUCARA P; MARINI U
    Atti Accad Med Lomb; 1964; 19():192-6. PubMed ID: 14296692
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction between the natriuretic effects of renal perfusion pressure and the antinatriuretic effects of angiotensin and aldosterone in control of sodium excretion.
    Young DB; Pan YJ
    J Physiol (Paris); 1984; 79(6):511-7. PubMed ID: 6399318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenic control of the blood pressure in hypertension.
    Kezdi P
    Cardiologia (Basel); 1967; 51(4):193-203. PubMed ID: 4302654
    [No Abstract]   [Full Text] [Related]  

  • 19. Interrelations of renin, angiotensin II, and sodium in hypertension and renal failure.
    Gavras H; Oliver JA; Cannon PJ
    Annu Rev Med; 1976; 27():485-521. PubMed ID: 779610
    [No Abstract]   [Full Text] [Related]  

  • 20. [CLINICAL AND HEMODYNAMIC STUDIES ON A NEW ANTIHYPERTENSIVE SUBSTANCE FROM THE THIAZIDE GROUP WITHOUT DIURETIC EFFECT].
    WOELFER HJ; SCHNEIDER KW; HOCHREIN H
    Arzneimittelforschung; 1963 Sep; 13():748-56. PubMed ID: 14114481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.